These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11073276)

  • 1. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.
    Klaus G; Watson A; Edefonti A; Fischbach M; Rönnholm K; Schaefer F; Simkova E; Stefanidis CJ; Strazdins V; Vande Walle J; Schröder C; Zurowska A; Ekim M;
    Pediatr Nephrol; 2006 Feb; 21(2):151-9. PubMed ID: 16247644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arguments justifying the measurement of the most relevant biochemical parameters to monitor bone and mineral metabolism in dialysis patients].
    Ureña Torres PA; Jean G
    Nephrol Ther; 2023 Aug; 19(4):293-296. PubMed ID: 37533272
    [No Abstract]   [Full Text] [Related]  

  • 3. Take actions to bridge the gaps between China and other countries: in the aspect of markers of mineral bone disease from China Dialysis Outcomes and Practice Patterns Study phase 5.
    Zhou L; Fu P
    Chin Med J (Engl); 2019 Dec; 132(23):2773-2774. PubMed ID: 31856046
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone Health ECHO Case Report: Fractures and Hypercalcemia in a Patient with Stage 5 Chronic Kidney Disease.
    Lewiecki EM; Erickson DG; Gildersleeve RW
    J Clin Densitom; 2024; 27(2):101478. PubMed ID: 38422629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in serum phosphate levels predict the long-term response to intravenous calcitriol therapy in dialysis patients with secondary hyperparathyroidism.
    Hosaka K; Kazama JJ; Yamamoto S; Ito Y; Iino N; Maruyama H; Saito A; Narita I; Gejyo F
    J Bone Miner Metab; 2008; 26(2):185-90. PubMed ID: 18301976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of renal osteopathy in patients with chronic dialysis].
    Kiss D; Brunner FP
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.
    Slatopolsky E; Rutherford WE; Martin K; Hruska K
    Adv Exp Med Biol; 1977; 81():467-75. PubMed ID: 899937
    [No Abstract]   [Full Text] [Related]  

  • 8. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 10. III. Clinical algorithms on renal osteodystrophy.
    Nephrol Dial Transplant; 2000; 15 Suppl 5():39-57. PubMed ID: 11073276
    [No Abstract]   [Full Text] [Related]  

  • 11. Disordered divalent ion metabolism in kidney disease: comments on pathogenesis and treatment.
    Brautbar N; Kleeman CR
    Adv Nephrol Necker Hosp; 1979; 8():179-205. PubMed ID: 227253
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.